Medical Automation Technologies, Products and Markets
October 04, 2011
Wellesley, Mass. – In a recent release, MEDICAL AUTOMATION TECHNOLOGIES, PRODUCTS AND MARKETS (HLC066B) from BCC Research (www.bccresearch.com), the U.S. market for medical automation products is expected to surpass $13 billion in 2011 and is forecast to exceed $21 billion in 2016, increasing at a five-year compound annual growth rate (CAGR) of 9.5%.
The U.S. market for medical automation can be broken down into three segments – therapy, diagnostic and monitoring, and logistics and training.
The therapy segment held a value of $8.9 billion in 2011, and is expected to increase at a CAGR of 8.9% to reach $13.6 billion in 2016.
The segment made up of diagnostic and monitoring devices held a value of $4.1 billion in 2011, and is expected to increase at a CAGR of 10.2% to reach $6.7 billion in 2016.
The segment made up of logistics and training held a value of $287 million in 2011, and is expected to increase at a CAGR of 18.4% to reach $668 billion in 2016.
The U.S. government and the healthcare industry have stepped up their efforts to increase the efficiency of healthcare, with the two main objectives being cost containment and improving the quality of care. Information technology is at the forefront of this effort; however, healthcare IT is just one segment of the broader field of medical automation, a field that many experts believe will revolutionize the way medical care is provided. Automated delivery of healthcare can contain costs, reduce errors, and improve outcomes.
Major improvements in production efficiency and product quality have been demonstrated through automation in factories. Medical automation will borrow many of the principles developed in factory automation and apply them to the medical environment. Automation will have to demonstrate, however, that it is safe for patients, that it has more flexibility to accommodate the complex tasks within the hospital, and that it can generate a reasonable return on investment.
This report is intended especially for healthcare automation suppliers, as well as government agencies, healthcare policy analysts, and others seeking to understand the costs and preconditions for success of healthcare automation initiatives. Others who will find the report useful include executive managers and marketing and financial analysts; and, although the report is not written specifically for scientists and technologists, its findings are concerned with the markets for their work, including the availability of government and corporate research funding for different technologies, and applications that should interest them as well.
Medical Automation Technologies, Products and Markets( HLC066B )
Publish Date: Sep 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand